Moderna Share Price

Moderna Share Price

NASDAQ: MRNA | Large Cap | Healthcare
$196.02
-$10.72 (-5.19%) Last updated on 19 Nov, 2026 | 02:51 IST
  • Performance
  • Chart
  • Fundamentals
  • Profit & Loss
  • Balance Sheet
  • Cash Flow
  • About
  • Price history
  • Similar Stocks
  • FAQs

Moderna Stock Performance

Open
$205.34
Prev. Close
$206.75
Circuit Range
N/A
Day Range
$196.55 - $208.19
Year Range
$22.28 - $280.74
Volume
2,65,022
Average Traded
$201.32

Moderna Share Price Today

As of 19 November 2026, Moderna, Inc.'s share price is $196.02. The stock opened at $205.34, compared to its previous close of $206.75. During today's trading session, Moderna, Inc.'s share price traded between $196.55 and $208.19, with an average price of $202.37. Over the past 52 weeks, the stock has recorded a high of $280.74 and a low of $22.28. In terms of performance, Moderna, Inc.'s share price has risen by 315.47% over the last six months and is up 654.79% on a year-on-year basis.

Moderna Share Price Chart

Line chart of the Moderna price trend over the selected period. The price fell overall, ranging from 196.72 to 208.19, ending at 196.76.
$196.55$208.19
L
Show Current Price
H

Moderna Stock Fundamentals & Key Indicators

Market Cap
$76.25B
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-6.89
Revenue (TTM)
$1.94B
Return On Equity (TTM)
-40.79%
Profit Margin
-145.36%
Debt to Equity
0.52
Quarterly Earnings Growth YoY
119.61%

Moderna Quarterly Profit & Loss

All figures in USD

ParticularsDec 2025Mar 2026Jun 2026Sep 2026
Revenue$678.00$389.00$145.00$1313.00
Net Profit-$826.00-$1343.00-$782.00$162.00
Net Profit Margin-121.83%-345.24%-539.31%12.34%
Income ChangeN/A-62.59%41.77%120.72%

Moderna Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$19.26$6.85$3.24$1.94
Net Profit$8.36-$4.71-$3.56-$2.82
Net Profit Margin43.41%-68.76%-109.88%-145.36%
Income ChangeN/A-156.34%24.42%20.79%

Moderna Balance Sheet

All figures in USD Billion

Particulars2025202420232022
Non Current Assets5.796.048.112.43
Current Assets6.548.110.3313.43
Total Assets12.3414.1418.4325.86
Non Current Liabilities1.71.041.561.81
Current Liabilities1.992.213.024.92
Total Liabilities3.693.244.576.74
Shareholders' Equity8.6510.913.8519.12

Moderna Cash Flow

Annually

All figures in USD Million

Particulars2025202420232022
Operating-1,873.0-3,004.0-3,118.04,981.0
Investing1,946.01,949.04,206.0-5,176.0
Financing593.056.0-1,377.0-3,448.0

About Moderna

Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in 2018. The firm's mRNA technology was rapidly validated with its covid vaccine, which was authorized in the United States in December 2020. Moderna had 25 mRNA development candidates in clinical studies as of March 2026. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.

Moderna Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Nov 2026
$223.84
$196.72
-11.33%
Oct 2026
$186.61
$221.85
+15.17%
Sep 2026
$139.40
$192.63
+34.98%
Aug 2026
$54.92
$142.71
+160.23%
Jul 2026
$70.28
$54.84
-21.66%
Jun 2026
$46.80
$70.00
+48.37%
May 2026
$46.43
$47.18
+2.79%
Apr 2026
$51.74
$45.90
-9.68%
Mar 2026
$52.42
$50.82
-5.20%
Feb 2026
$43.19
$53.61
+21.56%
Jan 2026
$29.87
$44.10
+49.54%
Dec 2025
$25.00
$29.49
+13.55%

Moderna Share Price FAQs